ArticleProstate international2026
Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies.
Article in Prostate international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to evaluate the relationship between specific baseline clinical factors and quality of life (QoL) outcomes at three months in men presenting with poor initial QoL. Methods: This multinational study was conducted a retrospective analysis of international data from men with poor baseline QoL scores (4, 5, or 6) who underwent Aquablation for benign prostatic hyperplasia (BPH). The study involved 310 men with QoL ≤2 and 104 men with QoL >2 at 3 months post-treatment. Baseline clinical characteristics were collected, including the International Prostate Symptom Score (IPSS) for storage and voiding, postvoid residual (PVR), Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD) and International Index of Erectile Function (IIEF-5) for sexually active men. Results: The study involved 310 men with QoL ≤2 and 104 men with QoL >2. The mean age for men with QoL ≤2 was 66.8 years (SD ± 7.5) and 68.3 years (SD ± 8.0) for those with QoL >2. The mean prostate volume was 72.1 mL (SD ± 31.2) for the QoL ≤2 group and 68.4 mL (SD ± 28.0) for the QoL >2 group. In the univariable logistic regression analysis, significant improvement in quality of life at 3 months was observed among patients with poor baseline QoL who had a high PVR volume (PVR >100 mL; OR = 1.737, Conclusion: In summary, this study adds to the growing evidence supporting Aquablation as an effective intervention for alleviating prostate symptoms and improving QoL in affected men with poor QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.